It was a dramatic implosion. Some of the biggest names in venture capital had poured cash into the company, believing it could become a giant of the money-spinning live events industry. Their dream evaporated when the events Pollen sold tickets for had to be cancelled during the Covid-19 pandemic. Within weeks, another side to the story began to emerge.
Former staff told of its founders – young entrepreneur brothers Callum and Liam Negus-Fancey – spending hundreds of thousands of pounds on parties where drugs were a common feature. One former employee said they remembered colleagues knocking back shots in the office on a weekday morning.
A spokesperson for Pollen countered that these tales were “grossly exaggerated”, and stressed that the pandemic, rather than the parties, were what capsized Pollen.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2023 @ growthinvest